Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Trials|April 13, 2021
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trialNikhil Vergis, Rachel Phillips, Victoria Cornelius, et al.
Gut|March 23, 2025
Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescenceDaniel Rodrigo-Torres, Alastair M Kilpatrick, Sofia Ferreira-Gonzalez, et al.
BMJ Open|February 5, 2026
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemicLorna Hazell, Clio Pillay, Victoria Cornelius, et al.
Scientific Reports|October 1, 2020
Transcutaneous fluorescence spectroscopy as a tool for non-invasive monitoring of gut function: first clinical experiencesJames Maurice, Aaron M Lett, Charlotte Skinner, et al.
The New England Journal of Medicine|April 23, 2015
Prednisolone or pentoxifylline for alcoholic hepatitisMark R Thursz, Paul Richardson, Michael Allison, et al.
Gastroenterology|December 6, 2014
Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTKChristine Bernsmeier, Oltin T Pop, Arjuna Singanayagam, et al.
BMJ (Clinical Research Ed.)|May 16, 2022
Visualising harms in publications of randomised controlled trials: consensus and recommendationsRachel Phillips, Suzie Cro, Graham Wheeler, et al.
Gut|February 11, 2016
Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidaseNikhil Vergis, Wafa Khamri, Kylie Beale, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of CanakinumabNikhil Vergis, Vishal Patel, Karolina Bogdanowicz, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Pageof 3